About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD0.97
- USD0.97
- USD0.93
- USD4.05
- -4.60%
- 2M
- 8.83k
- 33.72k
- 26M
- 0.79
- -75.90%
Stock News
1 hour ago
Broadway Financial Corporation Discloses Receipt of Notice From Nasdaq Regarding Filing Requirement for the Company’s Form 10-K
Yahoo
1 hour ago
Texas Instruments Stock Jumps as Earnings Edge Estimates
Yahoo
1 hour ago
Texas Instruments Gives Solid Forecast in Sign of Comeback
Yahoo
1 hour ago
Chipmaker Texas Instruments Beats Q1 Goals, Gives Reassuring Outlook
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
